查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146146

光疗市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

Light Therapy Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在研究期间（2022-2027 年），光疗市场预计将以 4.5% 的显着复合年增长率增长。

最近，各国面临着 COVID-19 的巨大威胁。 COVID-19 对所有主要器官系统都有重大影响。根据 2021 年 4 月发表的论文《蓝光的力量——从 COVID-19 中恢復的光疗》，蓝光疗法可提高 B-内啡□水平，降低收缩压、内皮功能和动脉可能对一系列这些持续症状有益，对改善僵硬有显着影响。研究表明蓝光疗法在治疗 COVID-19 应用患者方面的益处促进了采用，增加了对光疗法产品和服务的需求。随着光疗的益处和应用的扩大，光疗市场预计将在 COVID-19 之后增长。

研究的市场增长驱动因素包括皮肤相关疾病、精神疾病负担增加、投资增加、产品发布增加、研发活动增加以及主要市场参与者采用关键战略。

抑郁症、焦虑症和阿尔茨海默病等精神疾病的负担日益加重，对治疗这些疾病的药物的需求也在增加，而光疗法正被用于治疗此类疾病。例如，根据世界卫生组织（WHO）2021 年 9 月发表的一篇论文，抑郁症是一种常见的精神疾病，全球估计有 5.0% 的成年人患有抑郁症。它是全球残疾的主要原因之一。光疗法在抑郁症治疗中的应用越来越多，这些疾病的高患病率推动了市场的发展。

主要参与者采用的关键战略，例如兼併、收购、合作、投资和创新，可能会带来利润丰厚的市场增长。例如，2022 年 3 月，10X Health System 与 DaVinci Medical 合作，将 Superhuman Protocol 推向市场。 Superhuman Protocol 让客户体验全身 360 度全方位解决方案，从终生疏忽中恢復过来，自然地增强健康和表现。该协议分三个步骤设计，包括促进三磷酸腺甘 (ATP) 产生的 celalite 治疗床。因此，推动产品创新的合作伙伴关係将引领市场增长。

此外，2021 年 11 月，PHLECS 从 Metropoolregio Eindhoven 获得了 50,000 欧元的赠款，用于开展一个开发新一代光疗无蓝光-紫外线医疗设备的项目：Full Body Home Connected。该设备可以捕获患者的生物医学数据，以实现个性化治疗和未来基于人工智能的服务。因此，对所研究市场的巨额投资表明该市场具有巨大的创新和增长潜力，从而推动了研究期间的市场。

因此，由于上述因素，研究涵盖的市场预计在研究期间将显着增长。然而，与光疗相关的副作用增加和产品召回预计将阻碍研究期间的市场增长。

主要市场趋势

预计红灯部分将在预测期内占据最大的市场份额

红光疗法 (RLT) 或光生物调节是一种很有前途的新疗法，可用于治疗皱纹、发红、痤疮、疤痕和其他衰老迹象。这种治疗方法是无毒的、非侵入性的，并且比一些局部皮肤治疗方法更温和。红光疗法 (RLT) 是一种据报导使用低波长红光改善皮肤外观和治疗其他疾病的治疗方法。

新红光疗法产品和服务的推出、RLT 的日益普及、大规模投资、主要参与者采用关键战略以及不断增长的研发研究预计将推动研究中的市场。

2021 年 10 月，Lifepro 推出了其红光疗法系列，以提供价格具有竞争力的非侵入性健康护理。每种产品都针对身体的不同部位，并提供一套完整的套件来支持不同的疾病和健康目标。市场参与者推出此类疗法正在增加可及性并促进市场增长。

领先公司采用伙伴关係、合作和投资等重要战略将推动研究目标细分市场。例如，2022 年 2 月，UFC 表演研究所和 GameDay Ready 恢復区建立了合作伙伴关係，为所有 UFC 运动员提供红光疗法，以提高他们的表现。红光通过增加三磷酸腺甘 (ATP) 的产生和减少剧烈运动后的氧化应激，帮助身体在细胞水平上恢復最佳性能。

2022 年 2 月，Arizona Coyotes 与亚利桑那州的一家公司 Mito Red Light Inc. 合作，该公司开发红光疗法产品以支持恢復、表现和整体健康。这样，红光疗法在各个领域的立即采用将极大地促进市场的增长。

此外，越来越多的研究和开发证明红光疗法对各种疾病的有效性将促进市场研究。例如，根据clinicaltrials.gov，2021年3月，中山眼科中心（中山大学）对近视进展迅速的角膜塑形术治疗无反应者重复低水平红光控制近视。开始评估治疗（RLRL）和角膜塑形术（Ortho-k）的辅助效果。因此，此类研究的结果有望提高其适应性并带来丰厚的市场增长。

因此，由于上述因素，研究部门有望为市场的大幅增长做出贡献。

北美在市场中占有很大份额，预计在预测期内也会如此

北美光疗市场增长的主要驱动力是心理健康和皮肤相关疾病负担的增加、研发活动的增长、投资的增加、产品发布的增加、主要市场参与者的重大举措等。

皮肤相关疾病（如寻常痤疮、银屑病和白癜风）的负担日益加重，预计这将推动光疗市场对这些疾病的治疗。根据 2021 年 8 月发表的 Medscape 文章“关于美国寻常痤疮的发病率”，痤疮是美国最常见的皮肤病，每年影响 5000 万人。...寻常痤疮（粉刺）在某些时候影响了美国 80% 的人。严重的痤疮影响 20% 的人，据说会留下长期的身心伤疤。因此，寻常痤疮的高流行有望推动该国市场的增长。

在该地区推出的光疗产品和服务也将显着推动市场。例如，2021 年 11 月，Vital Red Light 将推出一系列新的家用、专业级红色和近红外光疗设备，让患者能够从舒适区获得光疗治疗。此外，2022 年 2 月，Oralucent 推出了一款获得多项专利的蓝光和红光光疗牙刷，用于安全有效地解决美白和其他常见牙齿问题。

此外，增加合作伙伴关係和增加市场主要参与者的投资等战略也将推动该地区的创新，从而推动该地区的市场。例如，2021 年 10 月，Zerigo Health 在由 7wireVentures 领投的一轮融资中获得了 4300 万美元。这将帮助 Zerigo 扩大其光疗系统的可用性，使其能够覆盖美国更大比例的慢性皮肤病患者。

该地区研究活动的进一步积极成果也将显着推动市场。例如，根据 Clinicaltrials.gov 的数据，该研究预计将于 2022 年 4 月开始，并由波特兰 VA 医学中心和俄勒冈健康与科学大学于 2026 年 8 月完成。本研究旨在评估晨光疗法改善脑外伤退伍军人睡眠的可行性和初步疗效。

因此，由于上述因素，预计所研究的市场将在北美带来利润丰厚的增长。

竞争格局

这个市场分散且竞争激烈。关键市场参与者很容易采用联合研究、併购、合作伙伴关係和投资等关键战略来推动市场发展。市场参与者包括 Koninklijke Philips N.V.、Verilux, Inc.、Northern、Light Technologies、Beurer、Zepter International 等。

其他特典

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第 1 章介绍

  • 研究假设和市场定义
  • 调查范围

第 2 章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 市场概览
  • 市场促进因素
    • 皮肤病和精神疾病负担不断增加
    • 启动研发
  • 市场抑制因素
    • 光疗带来的副作用和产品召回增加
  • 五力分析分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于金额，单位：百万美元）

  • 按产品类型
    • 灯箱
    • 落地灯/檯灯
    • 轻便的遮阳板
    • 黎明模拟器
    • 光疗仪
    • 手持设备
  • 按光源类型
    • 白光
    • 蓝光
    • 红灯
    • 其他（绿灯、黄灯）
  • 按用途
    • 维生素 D 缺乏症
    • 精神疾病
    • 皮肤病
    • 新生儿黄疸
  • 按最终用户
    • 皮肤科诊所
    • 家庭医疗
    • 其他（工作场所、沙龙等）
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海合会
      • 南非
      • 其他中东和非洲
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章竞争格局

  • 公司简介
    • Koninklijke Philips N.V.
    • Verilux, Inc.
    • Northern Light Technologies
    • Beurer
    • Zepter International
    • PhotoMedex, Inc.
    • Nature Bright
    • Lucimed SA
    • Carex
    • Lumie
    • Revian, Inc.
    • BioPhotas

第 7 章市场机会和未来趋势

简介目录
Product Code: 90795

The Light Therapy Market is expected to grow at a significant CAGR of 4.5% during the study period (2022-2027).

In recent times, countries have faced a huge threat of COVID-19. COVID-19 has a considerable effect on all major organ systems. According to the article "The Power of Blue Light - Phototherapy for Recovering From COVID-19," published in April 2021, blue light therapy had a significant influence on the increase of B-endorphin levels, reduction of systolic blood pressure, improving endothelial function and arterial stiffness and hence, blue light therapy could be beneficial for a range of these persistent symptoms. With research studies depicting the advantages of blue light therapy in treating patients with COVID-19 applications, it was readily adopted, boosting the demand for light therapy products and services. With light therapy's expanding benefits and applications, the market is expected to grow post-COVID-19.

The factors propelling the studied market growth are the growing burden of skin-related disorders, mental health disorders, rising investments, increasing product launches, growing research and development activities, and the adoption of key strategies by major market players.

The growing burden of mental health disorders such as depression, anxiety disorders, Alzheimer's diseases, and others is increasing the demand for its therapeutics, and light therapy is used to treat such disorders. For instance, as per the article published by World Health Organization (WHO) in September 2021, depression is a common mental disorder, and it is estimated that 5.0% of adults suffer from depression globally. It is one of the leading causes of disability worldwide. Increasing usage of light therapy in treating depression and a high prevalence of these diseases will propel the market.

The key strategies adopted by major players, such as mergers, acquisitions, partnerships, investments, and technological innovation, will lead to lucrative market growth. For instance, in March 2022, 10X Health System partnered with DaVinci Medical to bring the Superhuman Protocol to the market. The Superhuman Protocol allows the clients to experience a whole-body 360 solution to restore a lifetime of neglect and naturally boost health and performance. This protocol is designed in three steps, including the Thera Light therapy bed to accelerate the production of Adenosine Triphosphate (ATP). Thus, partnerships boosting product innovation will lead the market towards growth.

Additionally, in November 2021, PHLECS received EUR 50,000 grant from Metropoolregio Eindhoven to initiate the development project of a new generation of phototherapy blue light - UV-free medical device: the Full Body Home Connected. This device can capture patient biomedical data for personalized treatment and enable future artificial intelligence-based services. Thus, huge investments in the studied market indicate that market has huge potential for innovation and growth, thus driving the market during the study period.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, increasing side effects associated with light therapy and product recalls are expected to hinder the market growth during the study period.

Key Market Trends

Red Light Segment is Expected to Account for the Largest Market Share During the Forecast Period

Red light therapy (RLT) or photobiomodulation is an emerging treatment showing promise in treating wrinkles, redness, acne, scars, and other signs of aging. This therapy is not toxic, not invasive, and not as harsh as some topical skin treatments. Red light therapy (RLT) is a treatment that uses low wavelength red light to reportedly improve the skin's appearance and treat other medical conditions.

Launching new red light therapy products and services, increased adoption of RLT, huge investments, adoption of key strategies by major players, and rising research and development studies are expected to boost the studied market.

In October 2021, Lifepro launched its Red Light Therapy line to provide access to non-invasive wellness care at a competitive price. Each product targets different points on the body to provide a full suite of support for various ailments and wellness goals. Such launches of therapies by market players increase accessibility and thus boosts the market's growth.

Adopting key strategies such as partnerships and collaborations, investments, and others by major players will boost the studied segment. For instance, in February 2022, UFC Performance Institute and GameDay Ready Recovery Zone entered into a partnership to provide red light therapy to all UFC athletes, which will help in enhancing their performance. Red light helps return the body to optimal performance at a cellular level by Increasing adenosine triphosphate (ATP) production and reducing oxidative stress following challenging workouts.

In February 2022, the Arizona Coyotes partnered with Mito Red Light Inc., an Arizona-based company that develops red light therapy products to support recovery, performance, and overall health and wellness. Thus, the ready adoption of red-light therapy in various areas will drive the market growth significantly.

Additionally, rising research and development studies proving the efficacies of red light therapy in various diseases will boost the market studies. For instance, as per clinicaltrials.gov, a study was initiated by Zhongshan Ophthalmic Center, Sun Yat-sen University, in March 2021 to evaluate the adjunctive effect of repeated low-level red-light therapy (RLRL) and orthokeratology (ortho-k) on myopia control in ortho-k non-responders who have undergone ortho-k treatment but were still experiencing fast myopia progression. Thus, results from such research studies will increase its adaptability, leading to lucrative market growth.

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

The primary driving factors for the growth of the North American light therapy market are the growing burden of mental health and skin-related disorders, growing research and development activities, increasing investments, rising product launches, and key initiatives taken by the key market players.

The rising burden of skin-related disorders such as acne vulgaris, psoriasis, vitiligo, and others is expected to boost the light therapy market as they treat these disorders. According to a Medscape article published in August 2021 titled "How common is acne vulgaris in the United States?" acne is the most common skin condition in the United States, affecting 50 million people each year. Acne vulgaris affects 80% of people in the United States at some point. Severe acne affects 20% of people, causing long-term physical and mental scarring. Thus, the high prevalence of acne vulgaris is expected to boost the market growth in the country.

Launching the region's light therapy products and services will also drive the market significantly. For instance, in November 2021, Vital Red Light launched a new collection of at-home, professional-grade red and near-infrared light therapy devices, which will provide patients the accessibility to light therapy treatments from the comfort of their zone. Additionally, in February 2022, Oralucent launched its multi-patented, blue, and red-light emitting phototherapy toothbrush to address whitening and other common dental concerns safely and effectively.

Moreover, strategies such as rising partnerships and increasing investments by major players in the market will also boost innovation in the region, thereby boosting the market in the region. For instance, in October 2021, Zerigo Health received USD 43 million in the funding round led by 7wireVentures. This will help Zerigo in scaling up the availability of its phototherapy system and allow it to reach an even greater percentage of people living with chronic skin conditions in the United States.

The positive results from the research activities in the region will also drive the market significantly. For instance, as per Clinicaltrials.gov, a study was initiated by Portland VA Medical Center and Oregon Health and Science University in April 2022 and is estimated to be completed by August 2026. This study aimed to assess the feasibility and preliminary efficacy of morning bright light therapy to improve sleep in Veterans with traumatic brain injury.

Therefore, the studied market is expected to lead to lucrative growth in North America due to the above-mentioned factors.

Competitive Landscape

The studied market is fragmented and moderately competitive. Key strategies such as collaborations, mergers and acquisitions, partnerships, and investments, among others, are readily adopted by key market players, boosting the market. The major players in the market include Koninklijke Philips N.V., Verilux, Inc., Northern, Light Technologies, Beurer, and Zepter International, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Skin and Mental Health Disorders
    • 4.2.2 Increasing Research and Development Activities
  • 4.3 Market Restraints
    • 4.3.1 Increasing Side Effects Due to Light Therapy and Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product Type
    • 5.1.1 Light Box
    • 5.1.2 Floor and Desk Lamps
    • 5.1.3 Light Visor
    • 5.1.4 Dawn Simulator
    • 5.1.5 Light Therapy Bulbs
    • 5.1.6 Handheld Devices
  • 5.2 By Light Type
    • 5.2.1 White Light
    • 5.2.2 Blue Light
    • 5.2.3 Red Light
    • 5.2.4 Others (Green and Yellow Light)
  • 5.3 By Application
    • 5.3.1 Vitamin D Deficiency
    • 5.3.2 Mental Health Disorders
    • 5.3.3 Skin Disorders
    • 5.3.4 Neonatal Jaundice
  • 5.4 By End User
    • 5.4.1 Dermatology Clinics
    • 5.4.2 Home Care Settings
    • 5.4.3 Others (Workplace, Salons, etc.)
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips N.V.
    • 6.1.2 Verilux, Inc.
    • 6.1.3 Northern Light Technologies
    • 6.1.4 Beurer
    • 6.1.5 Zepter International
    • 6.1.6 PhotoMedex, Inc.
    • 6.1.7 Nature Bright
    • 6.1.8 Lucimed SA
    • 6.1.9 Carex
    • 6.1.10 Lumie
    • 6.1.11 Revian, Inc.
    • 6.1.12 BioPhotas

7 MARKET OPPORTUNITIES AND FUTURE TRENDS